{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:32:30Z","timestamp":1762507950015},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1097\/tp.0000000000003063","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:19:59Z","timestamp":1575908399000},"page":"e109-e110","source":"Crossref","is-referenced-by-count":2,"title":["Talimogene Laherparepvec Use in Kidney Transplant Recipient"],"prefix":"10.1097","volume":"104","author":[{"given":"Mallika","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Nephrology, Washington University School of Medicine, St. Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Johns Hopkins University, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Alhamad","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Washington University School of Medicine, St. Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"17","key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation.","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"R2-20231002","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/1060028017702654","article-title":"Talimogene laherparepvec: an oncolytic virus therapy for melanoma.","volume":"51","author":"Corrigan","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"4","key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection.","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"R4-20231002","article-title":"Poor outcomes with the use of checkpoint inhibitors in kidney transplant recipients.","author":"Venkatachalam","journal-title":"Transplantation"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40425-017-0250-5","article-title":"Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma.","volume":"5","author":"Schvartsman","year":"2017","journal-title":"J Immunother Cancer"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:08:07Z","timestamp":1696223287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003063","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}